Isabella Frigerio
University of Verona
CancerInternal medicineRadiologySurgeryPathologyOncologyRetrospective cohort studyRadiofrequency ablationPancreasAblationPancreaticoduodenectomySingle CenterAbdominal surgeryPancreatic cancerGemcitabineAdenocarcinomaLocally advancedDistal pancreatectomyPancreatic surgeryLocally advanced pancreatic cancerPan europeanGeneral surgeryMedicineGastroenterology
75Publications
19H-index
1,117Citations
Publications 83
Newest
#1Roberto GirelliH-Index: 20
#2Isabella FrigerioH-Index: 19
Last. Claudio BassiH-Index: 111
view all 7 authors...
Source
#1Giovanni ButturiniH-Index: 51
#2Alessandro GiardinoH-Index: 14
Last. Marco RameraH-Index: 10
view all 6 authors...
Source
#1Alessandro SarnoH-Index: 3
#2Giorgia TedescoH-Index: 4
Last. M. D‘OnofrioH-Index: 1
view all 10 authors...
Source
#1Jony van HilstH-Index: 16
#2Thijs de RooijH-Index: 18
Last. Mohammad Abu Hilal (University of Southampton)H-Index: 22
view all 73 authors...
Objective:The aim of this study was to compare oncological outcomes after minimally invasive distal pancreatectomy (MIDP) with open distal pancreatectomy (ODP) in patients with pancreatic ductal adenocarcinoma (PDAC).Background:Cohort studies have suggested superior short-term outcomes of MIDP vs. O
Source
#1Alessandro GiardinoH-Index: 14
#2Giulio Innamorati (University of Verona)H-Index: 21
Last. Claudio Bassi (University of Verona)H-Index: 111
view all 12 authors...
Abstract Objective/Background RFA of pancreatic cancer has been demonstrated to be feasible and safe with a positive impact on survival. The aim was to investigate whether an immune reaction is activated after locally advanced pancreatic cancer (LAPC) ablation. Methods Peripheral Blood samples were obtained preoperatively and on post-operative days 3–30. Evaluated parameters were: cells [CD4+, CD8+ and activated subsets, T-Reg, Monocytes, myeloid and plasmocytoid Dendritic cells (mDC and pDC)] a...
Source
#1Salvatore Paiella (University of Verona)H-Index: 24
#2Giuseppe Malleo (University of Verona)H-Index: 46
Last. Roberto Salvia (University of Verona)H-Index: 57
view all 16 authors...
Purpose SMAD4 mutational status correlates with pancreatic ductal adenocarcinoma (PDAC) failure pattern. We investigated in a subset of locally advanced patients submitted to radiofrequency ablation (RFA) whether the assessment of SMAD4 status is a useful way to select the patients.
Source
#1Salvatore PaiellaH-Index: 24
#2Gabriele CapursoH-Index: 56
Last. Alessandro ZerbiH-Index: 58
view all 11 authors...
Source
#1Isabella FrigerioH-Index: 19
#2Paolo RegiH-Index: 10
Last. Giovanni ButturiniH-Index: 51
view all 14 authors...
Background Recent papers consider surgery as an option for synchronous liver oligometastatic patients [metastatic pancreatic ductal adenocarcinoma (mPDAC)]. In this study, we present our series of resected mPDACs after neoadjuvant chemotherapy (nCT).
Source
#1Salvatore PaiellaH-Index: 24
#2Gabriele CapursoH-Index: 56
Last. Alessandro ZerbiH-Index: 58
view all 8 authors...
Source
#1Salvatore Paiella (University of Verona)H-Index: 24
#2Roberto Salvia (University of Verona)H-Index: 57
Last. Claudio Bassi (University of Verona)H-Index: 111
view all 8 authors...
Thanks to continuous research and investment in technology, the ablation of tumors has become common. Through the application of different types of energy is possible to induce cellular injury of the neoplastic tissue, leading to cellular death. Radiofrequency ablation (RFA) and irreversible electroporation (IRE) represent the most applied ablative techniques on pancreatic cancer. RFA and IRE, causing necrosis and apoptosis of neoplastic cells, are able to destroy neoplastic tissue, to drastical...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.